用机器学习分析阿尔茨海默病的语音特征:一项案例对照研究
Shinichi Noto1, Yuichi Sekiyama2, Ryo Nagata2
1Department of Rehabilitation, Niigata University of Health and Welfare, Niigata 950-3198, Japan.
Healthcare (Basel, Switzerland)
|November 9, 2024
概括
对语音模式的机器学习分析揭示了阿尔茨海默病 (AD) 患者的显著差异,为早期,非侵入性AD诊断提供了潜力. 这些言语不规则可以帮助区分AD患者和健康个体.
科学领域:
- 神经学 神经学
- 计算语言学 计算语言学
- 生物医学工程 生物医学工程
背景情况:
- 在阿尔茨海默病 (AD) 患者中观察到语音和语言变化.
- 机器学习 (ML) 可以分析语音不规则,以潜在的早期AD诊断.
研究的目的:
- 用ML识别阿尔茨海默病 (AD) 患者的独特语音特征.
- 评估这些语音特征在区分AD患者与健康对照者的有效性.
主要方法:
- 对83名阿尔茨海默病患者和75名健康老年参与者进行了认知评估 (例如,迷你精神状态检查).
- 语音记录被分析为光谱特征,强度,基本频率和时间变化.
- 包括后勤回归在内的ML算法用于评估语音特征.
主要成果:
- 在AD患者和健康对照人群之间,在大多数语音频谱元素和强度因子中发现了显著的差异.
- 后勤回归分析显示,在曲线下面的高面积是重心,斜度,度和标准偏差等光谱特征.
- 特定的语音特征在区分两组之间表现出强的表现.
结论:
- ML有效地识别了阿尔茨海默病 (AD) 患者和健康的老年人之间存在差异的语言特征.
- 这些发现支持使用语音分析作为早期AD检测的非侵入性工具的潜力.
- 对这些语音生物标志物的进一步研究可能会导致改善AD的诊断策略.
更多相关视频
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
769
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
7.9K
相关概念视频
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
